Collplant For Profit

CollPlant is a regenerative and aesthetic medicine company that develops technologies and products for tissue regeneration and organ manufacturing. The company's products are based on plant-based technology that enables the production of recombinant human type I collagen (rhCollagen), which is identical to the collagen produced by the human body. CollPlant is developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics. The company's rhCollagen offers numerous opportunities in medical aesthetics, such as regenerative dermal fillers and breast implants. CollPlant is also developing BioInk platforms based on recombinant human collagen for use in 3D bioprinting. The company has filed 11 patent families and has published 12 peer-reviewed publications. CollPlant's contact information is available on the website.

Investors

Headquarters: Rehovot, HaMerkaz, Israel
Funding Status: IPO
Employee Number: 51-100
Technology: Stem cells
Investor Type: For Profit
Founded Date: 1981-01-01
Industry: Regenerative Medicine
Register and Claim Ownership